All posts tagged 2009
Record Fourth Quarter Caps Strong Year for Medtronic
MINNEAPOLIS–(BUSINESS WIRE)–Medtronic, Inc. (NYSE: MDT): “Across businesses and geographies, we have been executing against our strategy, resulting in a record $4 billion quarter” First $4 Billion Sales Quarter in Company History Full Year Revenue of $15.8 Billion Increased 8 Percent …
Orthovita Reports 2009 Fourth Quarter and Year-End Financial Results
MALVERN, Pa., Mar 10, 2010 (BUSINESS WIRE) -- --Fourth quarter 2009 operating income of $385,000 compared to an operating loss of $670,000 in fourth quarter 2008; full year
Osteotech Reports Fourth Quarter and Full Year 2009 Financial Results
EATONTOWN, N.J., March 4 /PRNewswire-FirstCall/ -- Osteotech, Inc. (Nasdaq: OSTE), a leader in the emerging field of biologic products for regenerative healing, today reported financial results for the fourth quarter
NuVasive Reports Fourth Quarter and Full Year 2009 Financial Results
SAN DIEGO, Feb. 25 /PRNewswire-FirstCall/ -- NuVasive, Inc. , a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today financial
Greatbatch, Inc. Reports 2009 Fourth Quarter and Full Year Results
CLARENCE, N.Y., Feb 23, 2010 (BUSINESS WIRE) -- Greatbatch, Inc. (NYSE: GB), today announced results for its fourth quarter and year ended January 1, 2010:
- Sales for 2009 fourth
TranS1 Inc. Reports Operating Results for the Fourth Quarter of 2009
Highlights: Fourth quarter revenues were $6.3 million 674 TranS1 procedures performed globally in the quarter Gross margin was 79.9% for the quarter GAAP loss per share was $0.28 for the quarter Non-GAAP loss
Alphatec Spine Announces Fourth Quarter and Full Year 2009 Revenue and Financial Results
Annual Revenue of $132.2 Million -- 30% Growth Vs 2008; 2009 Adjusted EBITDA of $15 Million CARLSBAD, Calif., Feb 23, 2010 (GlobeNewswire via COMTEX News Network) -- Alphatec Holdings,
Medtronic Third Quarter Revenue Increases 10% to $3.851 Billion; Raises Lower End of EPS Guidance for Current Fiscal Year
MINNEAPOLIS, Feb 23, 2010 (BUSINESS WIRE) -- --International revenue of $1.615 billion grew 11% on a constant currency basis; 22% as reported --Free cash flow exceeds $1.3 billion; GAAP
Exactech 2009 Revenue Up 10% to $177M; Q4 Revenue Up 20% to $48.3M, EPS $0.04 includes Charge to Earnings for Estimated DOJ Settlement
GAINESVILLE, Fla., Feb 22, 2010 (BUSINESS WIRE) -- Exactech, Inc. (EXAC 18.25, +0.15, +0.83%), a developer and producer of bone and joint restoration products for hip, knee, extremities,
Orthofix International Announces Record Revenue in 4th Quarter 2009
BOSTON, Feb 17, 2010 (BUSINESS WIRE) -- --Q409 sales of spinal implants & biologics up 15% vs. prior year; sales of spine stimulation products grew 12% --Fourth quarter consolidated
DJO Incorporated Announces Financial Results for Fourth Quarter and Fiscal Year 2009
SAN DIEGO--(BUSINESS WIRE)--DJO Incorporated (“DJO” or the “Company”), a global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced financial results
Smith & Nephew’s 2009 profits rise 15 percent to $723 million
The British medical device maker's profits last year rose to $723 million on flat sales of $3.8 billion; fourth-quarter sales rose 11 percent and Q4 profits were up
Theragenics® Reports Record Revenue with 2009 Results
$78.3 Million is Highest Annual Revenue in 29-Year History Pro forma Organic Growth of 10% in Surgical Products Segment for 2009 Supply and Reseller Agreement with Core Oncology adds to
NeuroMetrix Reports 2009 Financial Results
WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), a health care company transforming patient care through neurotechnology, today announced its financial results for the three months and year ended
RTI Biologics Announces 2009 Year End, Fourth Quarter Results, Estimates 2010 Revenues and EPS
ALACHUA, Fla.--(BUSINESS WIRE)--RTI Biologics Inc. (RTI) (Nasdaq: RTIX), a leading processor of orthopedic and other biologic implants, reported operating results for the fourth quarter and full year